Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy

Levi, Marcel
December 2008
ACP Journal Club;12/16/2008, Vol. 149 Issue 6, p8
Academic Journal
The article offers information on effectiveness of low-molecular-weight heparin on knee arthroscopy patients. 1761 patients were examined at Abano Terme Clinic and University Hospital of Padua, Padua, Italy and the follow-up period went on till three months. It was observed that low-molecular-weight heparin for seven days was more effective than graduated compression stockings for preventing deep venous thrombosis in patients having knee arthroscopy.


Related Articles

  • LMW heparin may be better than stockings for thromboprophylaxis.  // Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p18 

    The article reports on a study conducted by Italian researchers with the Knee Arthroscopy Nadroparin Thromboprophylaxis (KANT) Study Group, which found that prophylactic low-molecular-weight heparin helps reduce the risk for deep venous thrombosis more than compression stockings in patients who...

  • Impact of Pharmacists' Interventions on Prescribing Patterns for the Treatment of VTE in Patients with Cancer. Steward, Vikki M.; Hamid, Hind; Hooker, Kimberly // Journal of Hematology Oncology Pharmacy;Dec2012, Vol. 2 Issue 4, p132 

    Background: Venous thromboembolism (VTE) is a common comorbidity and a significant complication among patients with cancer. Its management can be quite problematic for medical oncologists. Guidelines recommend low-molecular-weight heparin (LMWH) monotherapy for 6 months as the preferred...

  • Review: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancer. Verso, Melina; Iorio, Alfonso // ACP Journal Club;12/16/2008, Vol. 149 Issue 6, p9 

    The article offers information on effectiveness and safety of low-molecular-weight heparin and unfractionated heparin for perioperative thromboprophylaxis in cancer patients. In patients with cancer having surgery, perioperative low-molecular-weight heparin does not reduce mortality more than...

  • Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome? Gurjar, Mohan // Indian Journal of Critical Care Medicine;Jun2014, Vol. 18 Issue 6, p345 

    The article discusses a study on the effect of heparin thromboprophylaxis in critically ill patients. It depicts the pathogenesis of thrombosis, known as Virchow's Triad which causes hospital-acquired morbidity and mortality in intensive care unit (ICU) patients. It also mentions the essential...

  • Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer. Lee, Agnes Y. Y.; Kamphuisen, Pieter W.; Meyer, Guy; Bauersachs, Rupert; Janas, Mette S.; Jarner, Mikala F.; Khorana, Alok A. // JAMA: Journal of the American Medical Association;8/18/2015, Vol. 314 Issue 7, 10.1001/jama.2015.9243 p677 

    IMPORTANCE Low-molecular-weight heparin is recommended over warfarin for the treatment of acute venous thromboembolism (VTE) in patients with active cancer largely based on results of a single, large trial. OBJECTIVE To study the efficacy and safety of tinzaparin vs warfarin for treatment of...

  • Low molecular weight heparins come into their own. Pinkowish, Mary Desmond // Patient Care;12/15/1997, Vol. 31 Issue 20, p22 

    Reports that low molecular weight heparins provide safe, effective outpatient treatment of venous thrombosis, while highlighting studies conducted. Details on the application of low weight heparins; Findings of studies conducted; Reference to some of the methods used to treat the condition.

  • Low-Molecular-Weight Heparin versus Compression Stockings for Thromboprophylaxis after Knee Arthroscopy. Camporese, Giuseppe; Bernardi, Enrico; Prandoni, Paolo; Noventa, Franco; Verlato, Fabio; Simioni, Paolo; Ntita, Kadimashi; Salmistraro, Giovanna; Frangos, Christos; Rossi, Franco; Cordova, Rosamaria; Franz, Francesca; Zucchetta, Pietro; Kontothanassis, Dimitrios; Andreozzi, Giuseppe Maria // Annals of Internal Medicine;7/15/2008, Vol. 149 Issue 2, p73 

    Background: Knee arthroscopy, the most common orthopedic operation worldwide, carries a definite risk for deep venous thrombosis; however, postsurgical thromboprophylaxis is not routinely recommended. Objective: To evaluate whether low-molecular-weight heparin (LMWH) better prevents deep venous...

  • Venous thromboembolism prevention post neck of femur fractures -- does it make a difference? Faroug, Radwane; Konnuru, Shireesha; Min, San S.; Hussain, Fazleenah; Ampat, George // Thrombosis Journal;2008, Vol. 6, Special section p1 

    Neck of femur fractures predispose patients to venous thromboembolism (VTE). NICE has issued guideline 46 to reduce this risk through the use of antithrombic agents. We audited our department's VTE practise by reviewing the clinical notes of 123 consecutive patients with no exclusions. We found...

  • Bleeding Manifestations After Early Use of Low-Molecular-Weight Heparins in Blunt Splenic Injuries. Alejandro, Kathia V.; Acosta, José A.; Rodríguez, Pablo A. // American Surgeon;Nov2003, Vol. 69 Issue 11, p1006 

    Low-molecular-weight heparins (LMWHs) have emerged as an effective method for deep venous thrombosis (DVT) prophylaxis after major trauma. The early use of LMWH in patients with splenic injuries may result in increased rates of blood transfusions and failure of nonoperative management. A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics